Affimed Provides Follow-up Data of AFM24 plus Atezolizumab :

In 17 EGFR wild-type (EGFRwt) non-small cell lung cancer (NSCLC) patients who failed chemotherapy and PD-1/PD-L1, AFM24 plus atezolizumab achieved 4...

Related Keywords

Seoul , Soult Ukpyolsi , South Korea , Mannheim , Baden Wüberg , Germany , Ukraine , Russia , Texas , United States , Hye Ryun Kim , Mary Beth Sandin , Andreas Harstrick , Alexander Fudukidis , Artiva Allo , University Of Texas Md Anderson Cancer Center , Professor At Yonsei University College Of Medicine , Chief Medical , Chief Executive Officer , Yonsei University College , Cancer Center ,